Tarja‐Terttu Pelliniemi

1.2k citations
37 papers · 871 indexed · h-index 20

Tarja‐Terttu Pelliniemi

37 papers receiving 848 citations

Peers

Tarja‐Terttu Pelliniemi
Comparison fields: 5 of 82
  • Hematology 450
  • Oncology 265
  • Immunology 161
  • Genetics 80
  • Public Health, Environmental and Occupational Health 161
Replace Akiyoshi Miwa with:
Akiyoshi Miwa Japan
Karin Kolbe Germany
Renée M. Y. Barge Netherlands
T.J.M. de Witte Netherlands
John P. Whitecar United States
M. J. Barnett Canada
T. de Witte Netherlands
R Raimondi Italy
Navin Khattry India
A. C. Newland United Kingdom
Tarja‐Terttu Pelliniemi relative to Akiyoshi Miwa Japan Akiyoshi Miwa's profile →
Citations per field
00.5×3.6×
Akiyoshi Miwa · 1×
Citations per year

Countries citing papers authored by Tarja‐Terttu Pelliniemi

Since Specialization
Citations

This map shows the geographic impact of Tarja‐Terttu Pelliniemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarja‐Terttu Pelliniemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarja‐Terttu Pelliniemi more than expected).

Fields of papers citing papers by Tarja‐Terttu Pelliniemi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarja‐Terttu Pelliniemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarja‐Terttu Pelliniemi. The network helps show where Tarja‐Terttu Pelliniemi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tarja‐Terttu Pelliniemi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tarja‐Terttu Pelliniemi Line = papers co-authored together Tarja‐Terttu Pelliniemi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20138
2 201218
3 200923
4 200913
5 200719
6 200722
7 20037
8 200320
9 199735
10 199714
11 199728
12 19966
13 199671
14 199532
15 199441
16 19948
17 199439
18 199311
19 199311
20 19916

About Tarja‐Terttu Pelliniemi

Tarja‐Terttu Pelliniemi is a scholar working on Hematology, Genetics and Clinical Biochemistry, having authored 37 papers that have together received 871 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Immunotherapy and Immune Responses (4 papers), Renal cell carcinoma treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Hematology (450 citations), Oncology (265 citations) and Immunology (161 citations). Tarja‐Terttu Pelliniemi has collaborated with scholars based in Finland, Denmark and Sweden. Frequent co-authors include Toivo T. Salmi, Kari Remes, Anri Tienhaara, Kari Pulkki, Allan Rajamäki, Kerttu Irjala, Eeva Salminen, Markku Laakso, R Lahtinen and Seppo Pyrhönen. Their work appears in journals such as Cancer, Clinical Chemistry and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026